Endurant Capital Management LP Nu Cana PLC Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$4.02 - $9.05 $438,782 - $987,807
-109,150 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$5.55 - $8.48 $1.53 Million - $2.34 Million
-275,550 Reduced 71.63%
109,150 $666,000
Q3 2019

Nov 14, 2019
BUY
$6.95 - $10.71 $2.67 Million - $4.12 Million
384,700 New
384,700 $2.79 Million

Others Institutions Holding NCNA

# of Institutions
23
Shares Held
11.3M
Call Options Held
0
Put Options Held
0
View Full List

About NuCana plc

NCNA Quotes by TradingView
  • Ticker NCNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,196,000
  • Market Cap $146M
  • Description
  • NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...
More about NCNA
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email